Last reviewed · How we verify
Period I : CJ30001, Period II : HKB0701 and SLM0807
Period I : CJ30001, Period II : HKB0701 and SLM0807 is a Small molecule drug developed by HK inno.N Corporation. It is currently in Phase 1 development.
At a glance
| Generic name | Period I : CJ30001, Period II : HKB0701 and SLM0807 |
|---|---|
| Sponsor | HK inno.N Corporation |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Pharmacodynamic Study of SLM0807, HKB0701 and CJ30001 in Healthy Subject (PHASE1)
- A Pharmacokinetic Study of CJ30001 and HKB0701/SLM0807 in Healthy Subject (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Period I : CJ30001, Period II : HKB0701 and SLM0807 CI brief — competitive landscape report
- Period I : CJ30001, Period II : HKB0701 and SLM0807 updates RSS · CI watch RSS
- HK inno.N Corporation portfolio CI
Frequently asked questions about Period I : CJ30001, Period II : HKB0701 and SLM0807
What is Period I : CJ30001, Period II : HKB0701 and SLM0807?
Period I : CJ30001, Period II : HKB0701 and SLM0807 is a Small molecule drug developed by HK inno.N Corporation.
Who makes Period I : CJ30001, Period II : HKB0701 and SLM0807?
Period I : CJ30001, Period II : HKB0701 and SLM0807 is developed by HK inno.N Corporation (see full HK inno.N Corporation pipeline at /company/hk-inno-n-corporation).
What development phase is Period I : CJ30001, Period II : HKB0701 and SLM0807 in?
Period I : CJ30001, Period II : HKB0701 and SLM0807 is in Phase 1.